6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
9m ago	AOI Awarded $20.9M Texas Semiconductor Innovation Fund Grant to Advance Manufacturing in Sugar Land
9m ago	Mineros S.A. Q1 2026 Results Conference Call to Be Held May 7, 2026
27m ago	High Liner Foods Q1 2026 Earnings Conference Call Scheduled for Thursday, May 14, 2026 at 10:00 A.M. (ET)
27m ago	Bath & Body Works Appoints Veronique Gabai-Pinsky as Chief Brand & Product Officer
28m ago	Fifteen HBCUs Launch National Research Coalition to Accelerate Innovation and Expand Impact

About

Organogenesis Holdings Inc (NASDAQ:ORGO) — investor relations, events, news, and company updates on 6ix.

Latest News

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Financials

Revenue

$564.17 M

Market Cap

$288.16 M

P/E Ratio

14.93

EPS

0.15

Community Chat

Ask AI